Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

IFN-γ-induced CD4+ CADM1+ T cells emerged as malignancy-progressive biomarkers in EBV NK/T lymphoproliferative disorders and potential drivers of malignant expansion in AITL

Jian Li, Yan Zhang, Qinhuan Luo, Dao-Bin Zhou, Yiao Di, Wei Zhang, Chong Wei

Blood (2025) 146 (Supplement 1): 3530.

https://doi.org/10.1182/blood-2025-3530

Published: 2025

Journal Articles

Clonal hematopoiesis in t-follicular helper cell lymphoma: A prognostic biomarker and early event in lymphoma evolution

Chong Wei, Wei Zhang, Dao-Bin Zhou

Blood (2025) 146 (Supplement 1): 3521.

https://doi.org/10.1182/blood-2025-3521

Published: 2025

Journal Articles

Golidocitinib combined with CHOP in newly-diagnosed peripheral T-cell lymphoma: Preliminary Results from A phase 1/2 clinical trial

Chong Wei, Wei Zhang, Dao-Bin Zhou, Jian Li, Yan Zhang, Kaini Shen, Wei Wang, Zi Wang, Danqing Zhao, Jing Ruan, Huacong Cai, Yueying Mao

Blood (2025) 146 (Supplement 1): 6322.

https://doi.org/10.1182/blood-2025-6322

Published: 2025

Journal Articles

Circulating cell-free BRAFV600E as a biomarker in patients with erdheim-chester disease

Long Chang, Wei-tong Liu, He Lin, Wen Gao, Dao-Bin Zhou, Minghui Duan, Xin-Xin Cao

Blood (2025) 146 (Supplement 1): 2038.

https://doi.org/10.1182/blood-2025-2038

Published: 2025

Journal Articles

Detection of mutation in cell-free DNA predicts poor outcomes in adult patients with langerhans cell histiocytosis

Long Chang, He Lin, Wei-tong Liu, Zheng-Zheng Liu, Wen Gao, Dao-Bin Zhou, Minghui Duan, Xin-Xin Cao

Blood (2025) 146 (Supplement 1): 2035.

https://doi.org/10.1182/blood-2025-2035

Published: 2025

Journal Articles

Combination of mitoxantrone hydrochloride liposome with gemcitabine, cisplatin and dexamethasone (MGDP) in patients with relapsed or refractory peripheral T cell lymphoma: A prospective, single-arm, multicenter, Phase I/II study

Chong Wei, Yang Song, Shengyu Zhou, Shuangnian Xu, Hongmei Jing, Hui Liu, Wei Zhang, Dao-Bin Zhou

Blood (2025) 146 (Supplement 1): 5423.

https://doi.org/10.1182/blood-2025-5423

Published: 2025

Journal Articles

Chemotherapy-free induction with pomalidomide, orelabrutinib, and rituximab (POR) followed by high-dose methotrexate,rituximab and orelabrutinin (ROM) in newly diagnosed primary CNS lymphoma: Interim analysis of a phase II study

Yan Zhang, Huiying Zhu, Zhangyuting He, Danqing Zhao, Chong Wei, Jing Ruan, Jian Li, Wei Zhang, Dao-Bin Zhou

Blood (2025) 146 (Supplement 1): 5471.

https://doi.org/10.1182/blood-2025-5471

Published: 2025

Journal Articles

Exploration of optimal high-dose methotrexate-based therapy for patients with primary CNS lymphoma: A real-world study in China

Huiying Zhu, Zhangyuting He, Chong Wei, Jing Ruan, Danqing Zhao, Wei Zhang, Jian Li, Dao-Bin Zhou, Yan Zhang

Blood (2025) 146 (Supplement 1): 3693.

https://doi.org/10.1182/blood-2025-3693

Published: 2025

Journal Articles

High Resolution Chest Computed Tomography Responses for a Cohort of Erdheim-Chester Disease Patients with Pulmonary Involvement

Long Chang, Luo Wang, Min Lang, Dao-Bin Zhou, Wen Gao, Minghui Duan, Xin-xin Cao

Blood (2024) 144 (Supplement 1): 1792.

https://doi.org/10.1182/blood-2024-198148

Published: 2024

Journal Articles

A phase 2 prospective study of bortezomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed iMCD

Hao Zhao, Miao-yan Zhang, Kai-ni Shen, Jun Feng, Xin-xin Cao, Ming-hui Duan, Dao-bin Zhou, Lu Zhang, Jian Li

Blood (2023) 141 (21): 2654–2657.

https://doi.org/10.1182/blood.2023020009

Published: 2023

Includes: Supplemental data

Journal Articles

A Prospective Study of Bortezomib, Cyclophosphamide and Dexamethasone in Newly-Diagnosed Idiopathic Multicentric Castleman's Disease

Hao Zhao, Miaoyan Zhang, Yanying Yu, Xinxin Cao, Dao-Bin Zhou, Lu Zhang, Jian Li

Blood (2022) 140 (Supplement 1): 4442–4443.

https://doi.org/10.1182/blood-2022-166349

Published: 2022

Journal Articles

LRG1, a Novel Serum Biomarker for Idiopathic Multicentric Castleman Disease Activity

Miaoyan Zhang, Yan-Ying Yu, Xin-xin Cao, Dao-Bin Zhou, Jian Li, Lu Zhang

Blood (2022) 140 (Supplement 1): 11923–11924.

https://doi.org/10.1182/blood-2022-156572

Published: 2022

Journal Articles

A Prospective, Multicenter Study of Bortezomib, Cyclophosphamide and Dexamethasone in Relapsed/Refractory Idiopathic Multicentric Castleman's Disease

Lu Zhang, MD, Ming-nan Jia, MD, Ai-lin Zhao, MD, Jun Feng, MD, Xin-xin Cao, MD, Yan Zhang, MD, Ming-hui Duan, MD, Dao-Bin Zhou, Yujun Dong, MD, Jian Li, MD

Blood (2020) 136 (Supplement 1): 42.

https://doi.org/10.1182/blood-2020-140115

Published: 2020

Journal Articles

Treatment Outcome and Prognostic Factors for Adult Langerhans Cell Histiocytosis

Xinxin Cao, MD, Ming-hui Duan, MD, Ai-lin Zhao, Hao Cai, Jia Chen, Xue-min Gao, Ting Liu, Hua-cong Cai, MD, Lu Zhang, Jian Sun, MD, Zhi-yong Liang, MD, Dao-Bin Zhou, Jian Li, MD

Blood (2020) 136 (Supplement 1): 38.

https://doi.org/10.1182/blood-2020-138426

Published: 2020

Journal Articles

Unicentric Castleman Disease with High Inflammatory State: Surgical Treatment Is a Potential Cure

Miaoyan Zhang, Xinxin Cao, MD, Dao-Bin Zhou, Lu Zhang, MD, Jian Li, MD

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-134350

Published: 2020

Journal Articles

A Highly Heterogeneous Mutational Pattern in POEMS Syndrome

Jia Chen, Xue-min Gao, Hao Zhao, MD, Hao Cai, Lu Zhang, MD, Xin-xin Cao, MD, Dao-Bin Zhou, Jian Li, MD

Blood (2020) 136 (Supplement 1): 19.

https://doi.org/10.1182/blood-2020-134900

Published: 2020

Journal Articles

Impact of Hematologists' Personality and Behavioral Traits on Medical Decision-Making for Elderly Acute Myeloid Leukemia: A National Study in China

Xia Wu, MD, Yi-Nan Jiang, Yue-Lun Zhang, Jia Chen, Yue-ying Mao, Lu Zhang, MD, Dao-Bin Zhou, Xinxin Cao, MD, Jian Li, MD

Blood (2020) 136 (Supplement 1): 19.

https://doi.org/10.1182/blood-2020-135957

Published: 2020

Journal Articles

Characteristics of Serum Lipidome in Patients with POEMS Syndrome

Hao Zhao, MD, Xue-min Gao, Xinxin Cao, MD, Lu Zhang, MD, Dao-Bin Zhou, Jian Li, MD

Blood (2019) 134 (Supplement_1): 3082.

https://doi.org/10.1182/blood-2019-122239

Published: 2019

Journal Articles

Comprehensive Geriatric Assessment in Consecutive Newly-Diagnosed Elderly Multiple Myeloma Patients in China: A Multicentered, Prospective, Non-Interventional Study

Blood (2019) 134 (Supplement_1): 5493.

https://doi.org/10.1182/blood-2019-125447

Published: 2019

Journal Articles

Prevalence of Monoclonal Gammopathy of Undetermined Significance in a Large Population with Annual Physical Examination in Beijing, China

Jinuo Wang, MD, Jian-Hua Han, Yue-lun Zhang, Xin-xin Cao, Dao-Bin Zhou, Teng-da Xu, Wei Su, Jian Li, MD

Blood (2019) 134 (Supplement_1): 5519.

https://doi.org/10.1182/blood-2019-124715

Published: 2019

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

IFN-γ-induced CD4+ CADM1+ T cells emerged as malignancy-progressive biomarkers in EBV NK/T lymphoproliferative disorders and potential drivers of malignant expansion in AITL

Clonal hematopoiesis in t-follicular helper cell lymphoma: A prognostic biomarker and early event in lymphoma evolution

Golidocitinib combined with CHOP in newly-diagnosed peripheral T-cell lymphoma: Preliminary Results from A phase 1/2 clinical trial

Circulating cell-free BRAFV600E as a biomarker in patients with erdheim-chester disease

Detection of mutation in cell-free DNA predicts poor outcomes in adult patients with langerhans cell histiocytosis

Combination of mitoxantrone hydrochloride liposome with gemcitabine, cisplatin and dexamethasone (MGDP) in patients with relapsed or refractory peripheral T cell lymphoma: A prospective, single-arm, multicenter, Phase I/II study

Chemotherapy-free induction with pomalidomide, orelabrutinib, and rituximab (POR) followed by high-dose methotrexate,rituximab and orelabrutinin (ROM) in newly diagnosed primary CNS lymphoma: Interim analysis of a phase II study

Exploration of optimal high-dose methotrexate-based therapy for patients with primary CNS lymphoma: A real-world study in China

High Resolution Chest Computed Tomography Responses for a Cohort of Erdheim-Chester Disease Patients with Pulmonary Involvement

A phase 2 prospective study of bortezomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed iMCD

A Prospective Study of Bortezomib, Cyclophosphamide and Dexamethasone in Newly-Diagnosed Idiopathic Multicentric Castleman's Disease

LRG1, a Novel Serum Biomarker for Idiopathic Multicentric Castleman Disease Activity

A Prospective, Multicenter Study of Bortezomib, Cyclophosphamide and Dexamethasone in Relapsed/Refractory Idiopathic Multicentric Castleman's Disease

Treatment Outcome and Prognostic Factors for Adult Langerhans Cell Histiocytosis

Unicentric Castleman Disease with High Inflammatory State: Surgical Treatment Is a Potential Cure

A Highly Heterogeneous Mutational Pattern in POEMS Syndrome

Impact of Hematologists' Personality and Behavioral Traits on Medical Decision-Making for Elderly Acute Myeloid Leukemia: A National Study in China

Characteristics of Serum Lipidome in Patients with POEMS Syndrome

Comprehensive Geriatric Assessment in Consecutive Newly-Diagnosed Elderly Multiple Myeloma Patients in China: A Multicentered, Prospective, Non-Interventional Study

Prevalence of Monoclonal Gammopathy of Undetermined Significance in a Large Population with Annual Physical Examination in Beijing, China

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only